InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume $2.06 -0.58 (-21.97%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$2.20 +0.14 (+6.60%) As of 03/28/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock InMed Pharmaceuticals Short Interest DataInMed Pharmaceuticals (INM) has a short interest of 21,700 shares, representing 3.05% of the float (the number of shares available for trading by the public). This marks a -19.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 227,814 shares to cover all short positions.Current Short Interest21,700 sharesPrevious Short Interest26,900 sharesChange Vs. Previous Month-19.33%Dollar Volume Sold Short$61,194.00Short Interest Ratio0.0 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares1,207,000 sharesShort Percent of Float3.05%Today's Trading Volume37,830 sharesAverage Trading Volume227,814 sharesToday's Volume Vs. Average17% Short Selling InMed Pharmaceuticals? Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINM Short Interest Over TimeINM Days to Cover Over TimeINM Percentage of Float Shorted Over Time Remove Ads InMed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202521,700 shares $61,194.00 -19.3%3.1%0 $2.82 2/28/202526,900 shares $79,086.00 -25.1%3.8%0.1 $2.94 2/15/202535,900 shares $113,444.00 +8.5%5.0%0.1 $3.16 1/31/202533,100 shares $101,948.00 +1,125.9%N/A0.1 $3.08 1/15/20252,700 shares $11,718.00 -71.0%N/A0 $4.34 12/31/20249,300 shares $44,082.00 -30.1%N/A0.2 $4.74 12/15/202413,300 shares $69,958.00 +3.9%N/A0.3 $5.26 11/30/202412,800 shares $54,912.00 -50.6%N/A0.3 $4.29 11/15/202425,900 shares $110,852.00 -77.6%N/A0.5 $4.28 10/31/2024115,500 shares $30,711.45 +188.8%N/A0 $0.27 Get the Latest News and Ratings for INM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/15/202440,000 shares $8,760.00 -57.1%N/A0 $0.22 9/30/202493,200 shares $22,088.40 -82.6%N/A0 $0.24 9/15/2024534,900 shares $139,822.86 +55.3%N/A0.1 $0.26 8/31/2024344,500 shares $122,263.05 +818.7%N/A0 $0.35 8/15/202437,500 shares $5,400.00 -85.2%N/A0 $0.14 7/31/2024253,200 shares $44,512.56 +85.2%N/A0.2 $0.18 7/15/2024136,700 shares $36,457.89 +61.4%N/A0.1 $0.27 6/30/202484,700 shares $22,487.85 -43.5%N/A0.1 $0.27 6/15/2024150,000 shares $34,005.00 +252.9%N/A0.2 $0.23 5/31/202442,500 shares $12,537.50 -44.6%N/A0.1 $0.30 5/15/202476,700 shares $21,015.34 -78.6%N/A0.2 $0.27 4/30/2024359,000 shares $96,571.00 +213.5%N/A0.9 $0.27 4/15/2024114,500 shares $36,491.15 +1,011.7%N/A0.3 $0.32 3/31/202410,300 shares $3,749.20 -81.9%N/A0 $0.36 3/15/202457,000 shares $20,520.00 -13.9%N/A0.3 $0.36 2/29/202466,200 shares $27,473.00 -52.1%N/A0.3 $0.42 2/15/2024138,300 shares $47,990.10 +244.9%N/A0.7 $0.35 1/31/202440,100 shares $14,431.99 -43.4%N/A0.2 $0.36 1/15/202470,800 shares $27,081.00 -47.2%N/A0 $0.38 12/31/2023134,000 shares $55,744.00 +1,213.7%N/A0.1 $0.42 12/15/202310,200 shares $3,672.00 -65.9%N/A0 $0.36 11/30/202329,900 shares $13,156.00 +510.2%N/A0 $0.44 11/15/20234,900 shares $1,989.40 -74.1%N/A0 $0.41 10/31/202318,900 shares $9,143.82 +339.5%N/A0 $0.48 10/15/20234,300 shares $2,743.40 +377.8%N/A0 $0.64 9/30/2023900 shares $629.91 -90.1%N/A0 $0.70 9/15/20239,100 shares $7,683.13 -65.4%N/A0.2 $0.84 8/31/202326,300 shares $21,592.30 +64.4%N/A0.5 $0.82 8/15/202316,000 shares $14,961.60 -61.5%N/A0.2 $0.94 7/31/202341,500 shares $46,480.00 +112.8%N/A0.5 $1.12This trading frustration almost made me quit (Ad)This happened to me time and time again, and I wanted no more of it. That’s exactly why I set out to refine my strategy… And with the help of my good friend Nate, we have done exactly that… Now, I cannot promise future returns or against losses, but the real trades so far have been nothing but astounding. Turning my once 69% win rate, into 83.3% on real trades in the last two months. And instead of just telling you, I want to SHOW you. And you can check it out right here. 7/15/202319,500 shares $18,721.95 +2.6%N/A0.2 $0.96 6/30/202319,000 shares $17,480.00 -63.2%N/A0.2 $0.92 6/15/202351,600 shares $65,532.00 +4.7%N/A0.4 $1.27 5/31/202349,300 shares $66,062.00 -24.0%N/A0.1 $1.34 5/15/202364,900 shares $75,284.00 -30.8%N/A0.1 $1.16 4/30/202393,800 shares $112,560.00 -25.7%N/A0.2 $1.20 4/15/2023126,300 shares $157,875.00 +3.8%N/A0.2 $1.25 3/31/2023121,700 shares $131,436.00 -27.7%N/A0.2 $1.08 3/15/2023168,400 shares $178,504.00 +194.9%N/A0.2 $1.06 2/28/202357,100 shares $75,943.00 -15.8%N/A0.1 $1.33 2/15/202367,800 shares $113,226.00 -7.6%N/A0.1 $1.67 1/31/202373,400 shares $135,056.00 -75.4%N/A0.1 $1.84 1/15/2023297,800 shares $562,842.00 +443.4%3.8%0.3 $1.89 12/30/202254,800 shares $110,696.00 +13.0%0.7%0.1 $2.02 12/15/202248,500 shares $90,210.00 +62.8%0.6%0.1 $1.86 11/30/202229,800 shares $78,970.00 +223.9%0.4%0 $2.65 11/15/20229,200 shares $25,576.00 -32.9%0.1%0 $2.78 10/31/202213,700 shares $41,785.00 +121.0%0.2%0 $3.05 10/15/20226,200 shares $32,922.00 -83.9%0.1%0 $5.31 9/30/202238,600 shares $254,516.82 -57.3%0.5%0 $6.59 9/15/202290,300 shares $867,783.00 +12,800.0%1.2%0.1 $9.61 8/31/2022700 shares $4,165.00 -89.4%N/A0 $5.95 8/15/20226,600 shares $2,571.36 -62.5%0.1%0 $0.39 7/31/202217,600 shares $6,864.00 -18.9%0.2%0.1 $0.39 7/15/202221,700 shares $8,029.00 +6.4%0.3%0.1 $0.37 6/30/202220,400 shares $9,596.16 -80.1%0.3%0.1 $0.47 6/15/2022102,300 shares $53,400.60 +47.6%1.3%0.5 $0.52 5/31/202269,300 shares $53,361.00 -29.4%0.9%0.3 $0.77 5/15/202298,100 shares $81,423.00 -34.3%1.3%0.5 $0.83 4/30/2022149,300 shares $135,863.00 -8.7%1.9%0.7 $0.91 4/15/2022163,600 shares $142,806.44 +34.1%2.1%0.8 $0.87 3/31/2022122,000 shares $115,009.40 +114.4%1.6%0.9 $0.94 3/15/202256,900 shares $41,024.90 -35.3%0.7%0.6 $0.72 2/28/202287,900 shares $82,819.38 +2.6%1.1%0.8 $0.94 2/15/202285,700 shares $99,412.00 -2.7%1.1%0.3 $1.16 1/31/202288,100 shares $106,601.00 -15.7%1.1%0 $1.21 1/15/2022104,500 shares $129,580.00 +74.5%1.3%0 $1.24 12/31/202159,900 shares $78,469.00 -8.4%0.8%0 $1.31 12/15/202165,400 shares $96,792.00 -56.5%0.8%0 $1.48 11/30/2021150,400 shares $285,760.00 +69.9%1.9%0.1 $1.90 11/15/202188,500 shares $118,590.00 -19.7%1.1%0 $1.34 10/29/2021110,200 shares $168,055.00 +69.3%1.4%0.2 $1.53 10/15/202165,100 shares $91,140.00 -2.5%0.8%0.1 $1.40 9/30/202166,800 shares $116,900.00 +189.2%0.8%0.3 $1.75 9/15/202123,100 shares $47,553.66 +216.4%0.3%0.2 $2.06 8/31/20217,300 shares $16,133.00 -92.4%0.1%0.1 $2.21 8/13/202196,600 shares $231,840.00 -47.8%1.2%1.4 $2.40 7/30/2021185,100 shares $516,429.00 +98.2%2.3%2.6 $2.79 7/15/202193,400 shares $249,378.00 +396.8%1.2%1.3 $2.67 6/30/202118,800 shares $59,784.00 +37.2%0.2%0.2 $3.18This trading frustration almost made me quit (Ad)This happened to me time and time again, and I wanted no more of it. That’s exactly why I set out to refine my strategy… And with the help of my good friend Nate, we have done exactly that… Now, I cannot promise future returns or against losses, but the real trades so far have been nothing but astounding. Turning my once 69% win rate, into 83.3% on real trades in the last two months. And instead of just telling you, I want to SHOW you. And you can check it out right here. 6/15/202113,700 shares $39,045.00 -2.8%0.2%0.2 $2.85 5/28/202114,100 shares $41,595.00 +30.6%0.2%0.2 $2.95 5/14/202110,800 shares $30,348.00 -90.7%0.1%0.1 $2.81 4/30/2021115,800 shares $431,934.00 -14.7%1.5%0.7 $3.73 4/15/2021135,800 shares $435,918.00 -64.8%1.7%0.7 $3.21 3/31/2021385,200 shares $1.21 million -6.6%4.8%1.8 $3.13 3/15/2021412,600 shares $1.96 million +0.3%5.2%1.8 $4.75 2/26/2021411,400 shares $1.80 million +7.3%5.9%1.7 $4.37 2/12/2021383,500 shares $2.05 million +177.1%5.5%1.6 $5.35 1/29/2021138,400 shares $546,693.84 +63.2%2.0%0.6 $3.95 1/15/202184,800 shares $367,184.00 No Change1.2%0.7 $4.33 INM Short Interest - Frequently Asked Questions What is InMed Pharmaceuticals' current short interest? Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 21,700 shares of INM short. 3.05% of InMed Pharmaceuticals' shares are currently sold short. Learn More on InMed Pharmaceuticals' current short interest. What is a good short interest percentage for InMed Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.05% of InMed Pharmaceuticals' floating shares are currently sold short. Is InMed Pharmaceuticals' short interest increasing or decreasing? InMed Pharmaceuticals saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 21,700 shares, a decrease of 19.3% from the previous total of 26,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does InMed Pharmaceuticals' short interest compare to its competitors? 3.05% of InMed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InMed Pharmaceuticals: Marker Therapeutics, Inc. (4.99%), Spruce Biosciences, Inc. (0.71%), HCW Biologics Inc. (1.70%), ImmunoPrecise Antibodies Ltd. (14.01%), Citius Pharmaceuticals, Inc. (6.39%), Athira Pharma, Inc. (2.91%), Biomerica, Inc. (0.32%), Minerva Neurosciences, Inc. (0.48%), Orgenesis Inc. (0.29%), Flora Growth Corp. (3.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short InMed Pharmaceuticals stock? Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading down $0.58 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InMed Pharmaceuticals? A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further. How often is InMed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Marker Therapeutics Short Interest Spruce Biosciences Short Interest HCW Biologics Short Interest ImmunoPrecise Antibodies Short Interest Citius Pharmaceuticals Short Interest Athira Pharma Short Interest Biomerica Short Interest Minerva Neurosciences Short Interest Orgenesis Short Interest Flora Growth Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INM) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
